Journal of South Asian Federation of Obstetrics and Gynaecology

Register      Login

VOLUME 7 , ISSUE 2 ( May-August, 2015 ) > List of Articles

EDITORIAL 2

Polycystic Ovary Syndrome: From in utero to Menopause

Citation Information : Polycystic Ovary Syndrome: From in utero to Menopause. J South Asian Feder Obs Gynae 2015; 7 (2).

DOI: 10.5005/jsafog-7-2-v

Published Online: 01-06-2010

Copyright Statement:  Copyright © 2015; The Author(s).


Abstract

PDF Share
  1. Controversy in clinical endocrinology: diagnosis of polycystic ovarian syndrome: the Rotterdam criteria are premature. J Clin Endocrinol Metab. 2006;91(3):781-785.
  2. ‘Polycystic Ovarian Syndrome. Medicine (2011 25 October). Retrieved 19 November 2011.
  3. Endocrine Society. Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2013;98(12):4565-4592.
  4. Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the androgen excess and polycystic ovary syndrome (AE-PCOS) Society. J Clin Endocrinol Metab 2010;95(5):2038-2049.
  5. Identification of a polycystic ovary syndrome susceptibility variant in fibrillin-3 and association with a metabolic phenotype. J Clin Endocrinol Metab 2007;92(11):4191-4198.
  6. Variants in DENND1A are associated with polycystic ovary syndrome ii women of European ancestry. J Clin Endocrinol Metab 2012;97(7):E1342-E1347.
  7. Sheep models of polycystic ovary syndrome phenotype. Mol Cell Endocrinol 2013;373(1):8-20.
  8. Androgen concentrations in umbilical cord blood and their association with maternal, fetal and obstetric factors. PLoS One 2012;7(8):e42827
  9. Early puberty-menarche after precocious pubarche: relation to prenatal growth. Pediatrics. 2006;117(1):117-121.
  10. Fetal growth, length of gestation, and polycystic ovaries in adult life. Lancet 1997;350(9085):1131-1135.
  11. Increased anti-Müllerian hormone serum concentrations in prepubertal daughters of women with polycystic ovary syndrome. J Clin Endocrinol Metab 2006;91(8):3105-3109.
  12. Adrenal function during childhood and puberty in daughters of women with polycystic ovary syndrome. J Clin Endocrinol Metab 2009;94(9):3282-3288.
  13. The diagnosis of polycystic ovary syndrome in adolescents. Am J Obstet Gynecol 2010;203(3): 201-205.
  14. Metabolic features of polycystic ovary syndrome are found in adolescent girls with hyperandrogenism. J Clin Endocrinol Metab 1995;80(10):2966-2973.
  15. Determinants of abnormal gonadotropin secretion in clinically defined women with polycystic ovary syndrome. J Clin Endocrinol Metab 1997;82(7):2248-2256.
  16. Relationship between Anti-Müllerian hormone (AMH) and insulin levels during different tanner stages in daughters of women with polycystic ovary syndrome. Reprod Sci 2012;19(4):383-390.
  17. Environmental and genetic factors influence age at menarche in women with polycystic ovary syndrome. J Pediatr Endocrinol Metab 2012;25(5-6):459-466.
  18. The epidemiology of infertility in the North East of Scotland. Hum Reprod 2009;24(12): 3096-3107.
  19. Long-term follow-up of patients with polycystic ovary syndrome: reproductive outcome and ovarian reserve. Hum Reprod 2009;24(5):1176-1183.
  20. Androgen levels in adult females: changes with age, menopause and oophorectomy. J Clin Endocrinol Metab 2005;90(7):3847-3853.
  21. Cardiovascular disease and risk factors in PCOS women of postmenopausal age: a 21-year controlled follow-up study. J Clin Endocrinol Metab 2011;96(12):3794-3803.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.